Of HMI. During the Term, so long as HMI is the Commercializing Party for the U.S. [***] Product and subject to Article 8 (Manufacturing and Technology Transfer), HMI will [***] Commercialize each In-Vivo [***] Product in the U.S. following the receipt of Marketing Approval from the FDA in the U.S. for such In-Vivo [***] Product.
Appears in 3 contracts
Samples: Collaboration and License Agreement (Homology Medicines, Inc.), Collaboration and License Agreement (Homology Medicines, Inc.), Collaboration and License Agreement (Homology Medicines, Inc.)
Of HMI. During the Term, so long as HMI is the Commercializing Party for the U.S. [***] SCD Product and subject to Article 8 (Manufacturing and Technology Transfer), HMI will [***] Commercialize each In-Vivo [***] SCD Product in the U.S. following the receipt of Marketing Approval from the FDA in the U.S. for such In-Vivo [***] SCD Product.
Appears in 1 contract
Samples: Collaboration and License Agreement (Homology Medicines, Inc.)